Wacker Biosolutions to focus on biotechnology
Wacker Fine Chemicals becomes Wacker Biosolutions and concentrates on biotechnology
Wacker Biosolutions will concentrate on building its business in three main areas, including pharmaceuticals, alongside its existing portfolio of fine chemicals and chemical intermediates. Its biotech products include cyclodextrins, cysteine and biologics, as well as fine chemicals and PVAc solid resins.
The Munich-based firm is currently extending process development and production capacities for the manufacture of pharmaceutical proteins at Wacker Biotech in Jena, Germany.
Wacker aims to offer tailored complete solutions to customers, taking advantage of the synergies between its chemical and biotech expertise. It sees potential in providing innovative products and technologies in the budding market for bioengineered products.
"This reorganisation lays further foundations for Wacker's future success in the growing field of biotechnology," said Gerhard Schmid, senior vice president of Wacker Biosolutions.
Over the past few years, Wacker has posted high double-digit growth with biotech products such as cyclodextrins and cysteine. The group sees future global-market potential in pharmaceutical actives, food additives and agrochemicals.
You may also like
Manufacturing
![TurboFil introduces Benchtop Version of Precision Unidose and Bi-dose Vial Filler and Stoppering System]()
TurboFil introduces Benchtop Version of Precision Unidose and Bi-dose Vial Filler and Stoppering System
Read moreCompany’s manual UDS/BDS Benchtop Vial Filler utilises same technique as its higher-volume automatic systems, simplifying lab-scale filling while easing downstream scale-up
Trending Articles
You may also like
Regulatory
![NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development]()
NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development
The discussion underscored the growing importance of aligning employee behaviours with compliance objectives, while also addressing the industry’s ongoing challenges around regulatory benchmarking and operational consistency
Manufacturing
![Alcami invests in quality, packaging and storage upgrades at Tennessee site post-Tjoapack acquisition]()
Alcami invests in quality, packaging and storage upgrades at Tennessee site post-Tjoapack acquisition
The CDMO is integrating the facility into its MasterControl QMS network, adding serialisation-ready packaging lines and expanded GMP temperature-controlled storage, with a new high-speed bottle line live in H1 2027
Design & Build
![Single Use Support launches RoSS.BLST blast freezer with -80 °C recipe-driven protocols]()
Single Use Support launches RoSS.BLST blast freezer with -80 °C recipe-driven protocols
The 21 CFR Part 11 compliant platform offers 30% more chamber capacity within the same footprint, supporting up to 192 × 2L bottles per batch for consistent, scalable biologics freeze-thaw processes
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![Neuland Laboratories announces new $20m process development lab in Hyderabad]()
Neuland Laboratories announces new $20m process development lab in Hyderabad
The new facility will be fully operational by October 2026 and will give clients earlier manufacturability insight when looking to scale up, through the incorporation of non-GMP kilo labs as well as AI-driven route scouting, parallel synthesis and ELNs